Studies on Chemical Characterization of Ginkgo Amillaria Oral Solution and Its Drug–Drug Interaction With Piceatannol 3′-O-β-D-Glucopyranoside for Injection
Ginkgo Amillaria oral solution (GAO) is commonly used for the treatment of cardiovascular and cerebrovascular diseases in China. Piceatannol-3′-O-β-D-glucopyranoside for injection (PGI) is mainly used for the prevention and treatment of ischemic cerebrovascular diseases. With the spread of cerebrova...
Main Authors: | Zhenyan Yu, Xiaohan Hu, Lin Zhou, Huliang Chen, Yanchao Xing, Chunyue Han, Hui Ding, Lifeng Han, Guixiang Pan, Zhifei Fu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-07-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.932646/full |
Similar Items
-
Investigating the chemical profile of Rheum lhasaense and its main ingredient of piceatannol-3′-O-β-D-glucopyranoside on ameliorating cognitive impairment
by: Yue Wang, et al.
Published: (2023-04-01) -
Piceatannol-3′-O-β-D-glucopyranoside attenuates colistin-induced neurotoxicity by suppressing oxidative stress via the NRF2/HO-1 pathway
by: Liguang Xiong, et al.
Published: (2023-05-01) -
Piceatannol as an Antiviral Inhibitor of PRV Infection In Vitro and In Vivo
by: Zhiying Wang, et al.
Published: (2023-07-01) -
Piceatannol Affects Gastric Ulcers Induced by Indomethacin: Association of Antioxidant, Anti-Inflammatory, and Angiogenesis Mechanisms in Rats
by: Rasheed A. Shaik, et al.
Published: (2022-02-01) -
Piceatannol Prevents Obesity and Fat Accumulation Caused by Estrogen Deficiency in Female Mice by Promoting Lipolysis
by: Kotoko Arisawa, et al.
Published: (2023-03-01)